Ajooni Biotech Limited — Board Meeting, 14-08-2025: Outcome of Board Meeting

Ajooni Biotech's board meeting approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs 31.27 Cr, though net profit for the quarter came in at Rs 0.78 Cr, a notable decline from the previous year. Additionally, the board re-appointed Mr. Gursimran Singh as Whole Time Director for five years, pending shareholder approval. Mr. Singh, with over 15 years of experience in animal husbandry and agriculture, has been the CEO for eight years, reinforcing the leadership.